EpiCast Report: Alzheimer's Disease - Epidemiology Forecast to 2026

2017-10-12
Price :
Published : Oct-2017
No. of Pages : 37
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Executive Summary 4
2.1 Related Reports 6
2.2 Upcoming Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 9
3.4 Forecast Methodology 11
3.4.1 Sources 11
3.4.2 Forecast Assumptions and Methods 14
3.4.3 Total Prevalent Cases of AD 14
3.4.4 Total Prevalent Cases of AD by Severity 17
3.4.5 Total Prevalent Cases of MCI 20
3.5 Epidemiological Forecast for AD (2016-2026) 22
3.5.1 Total Prevalent Cases of AD 22
3.5.2 Age-Specific Total Prevalent Cases of AD 23
3.5.3 Sex-Specific Total Prevalent Cases of AD 24
3.5.4 Total Prevalent Cases of AD by Severity 25
3.6 Epidemiological Forecast for MCI (2016-2026) 26
3.6.1 Total Prevalent Cases of MCI 26
3.6.2 Age-Specific Total Prevalent Cases of MCI 27
3.6.3 Sex-Specific Total Prevalent Cases of MCI 28
3.7 Discussion 29
3.7.1 Epidemiological Forecast Insight 29
3.7.2 Limitations of Analysis 29
3.7.3 Strengths of Analysis 30
4 Appendix 31
4.1 Bibliography 31
4.2 About the Authors 35
4.2.1 Epidemiologist 35
4.2.2 Reviewers 35
4.2.3 Global Director of Therapy Analysis and Epidemiology 36
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 36
4.3 About GlobalData 37
4.4 Contact Us 37
4.5 Disclaimer 37

1.1 List of Tables
Table 1: DSM-IV Criteria for the Diagnosis of Dementia 8
Table 2: NINCDS-ADRDA Criteria for the Diagnosis of AD 8
Table 3: Risk Factors and Comorbidities for AD 9
Table 4: 7MM, Total Prevalent Cases of AD, Both Sexes, Ages ?60 Years, Selected Years 2016-2026. 22
Table 5: 7MM, Total Prevalent Cases of MCI, Both Sexes, Ages ?60 Years, Selected Years 2016-2026. 26

1.2 List of Figures
Figure 1: 7MM, Total Prevalent Cases of AD, Both Sexes, Ages ?60 Years, 2016 and 2026 5
Figure 2: 7MM, Total Prevalent Cases of MCI, Both Sexes, Ages ?60 Years , 2016 and 2026 5
Figure 3: 7MM, Age-Standardized Total Prevalence of AD (%), Ages ?60 Years 10
Figure 4: 7MM, Age-Standardized Total Prevalence of MCI (%), Ages ?60 Years 11
Figure 5: 7MM, Sources Used and Not Used, Total Prevalent Cases of AD 12
Figure 6: 7MM, Sources Used, Total Prevalent Cases of AD by Severity 13
Figure 7: 7MM, Sources Used, Total Prevalent Cases of MCI 14
Figure 8: 7MM, Age-Specific Total Prevalent Cases of AD, Both Sexes, 2016 23
Figure 9: 7MM, Sex-Specific Total Prevalent Cases of AD, Both Sexes, Ages >60 Years, 2016 24
Figure 10: 7MM, Total Prevalent Cases of AD by Severity, Both Sexes, Ages ?60 Years, 2016 25
Figure 11: 7MM, Age-Specific Total Prevalent Cases of MCI, Both Sexes, 2016 27
Figure 12: 7MM, Sex-Specific Total Prevalent Cases of MCI, Both Sexes, Ages >60 Years, 2016 28
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData